SCHEMBL14083771

SCHEMBL14083771

CCN(CC)c1ccc(NC(=O)c2ccc(-c3ncccc3Cl)c(OC)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.54
▸ MAPT P10636 4/20 0.54
▸ NPSR1 Q6W5P4 2/20 0.54
▸ GAA P10253 1/20 0.54
▸ HTT P42858 1/20 0.54
▸ KMT2A Q03164 4/20 0.52
▸ MEN1 O00255 3/20 0.52
▸ LMNA P02545 2/20 0.52
▸ AURKB Q96GD4 1/20 0.51
▸ MAPK1 P28482 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ GFER P55789 1/20 0.50
▸ GHSR Q92847 5/20 0.49
▸ TRPV1 Q8NER1 3/20 0.48
▸ POLB P06746 3/20 0.47
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 1/20 0.45
▸ PKM P14618 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083298 0.91 GHSR (0.54) ALDH1A1MAPTNPSR1GAAHTT
SCHEMBL14083374 0.89 MAPT (0.53) ALDH1A1MAPTNPSR1GAAHTT
SCHEMBL14083835 0.88 AURKB (0.56) ALDH1A1KMT2AMEN1LMNAAURKB
SCHEMBL14083840 0.87 NPC1 (0.56) ALDH1A1MAPTGAAKMT2AMEN1
SCHEMBL14083673 0.87 LMNA (0.53) ALDH1A1MAPTNPSR1HTTKMT2A
SCHEMBL14083730 0.87 AURKB (0.55) ALDH1A1MAPTKMT2AMEN1LMNA
SCHEMBL14083841 0.87 AURKB (0.55) ALDH1A1MAPTKMT2AMEN1LMNA
SCHEMBL14083729 0.87 AURKB (0.57) ALDH1A1MAPTGAAKMT2AMEN1
SCHEMBL14083809 0.86 MAPT (0.58) ALDH1A1MAPTGAAKMT2AMEN1
SCHEMBL14083731 0.86 AURKB (0.54) ALDH1A1KMT2AMEN1LMNAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 ALDH1A1 1577/4885MAPT 2822/4885NPSR1 406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback